US · Healthcare · Drug Manufacturers - General
EPS came in at -0.21 against a street estimate of -0.14 — a miss of 50.0%.
Analysts rate Medicus Pharma Ltd. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $4.50.
| Fund | Stake |
|---|---|
| Interchange Capital Partners, LLC | 2.21% |
| Jane Street Group LLC | 0.47% |
| XTX Topco Ltd | 0.34% |
| Sterling Investment Advisors Ltd | 0.14% |
| Commonwealth Equity Services, LLC | 0.07% |
| May Hill Capital, LLC | 0.07% |
| Susquehanna International Group, LLP | 0.04% |
| Stifel Financial Corp | 0.04% |
| Action | Detail | Date |
|---|---|---|
| Split | 1 : 50 effective Oct 12, 2026 | 2026-10-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Medicus Pharma Ltd. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.